Combining sermorelin with Zepbound creates a dual-action metabolic effect: Zepbound (tirzepatide) reduces appetite and slows gastric emptying through GLP-1 and GIP receptor activation, while sermorelin stimulates pulsatile growth hormone release that enhances lipolysis and preserves lean tissue during caloric restriction
, even in those with low testosterone levels, due to its suppressive effect on the HPG axis
The PlexusDx Precision Peptide Genetic Test identifies your GLP-1R variants and other peptide pathway markers that influence how your body responds to semaglutide
Improving leptin sensitivity helps the body regulate hunger and metabolism more effectively, leading to sustainable weight loss
Control Copper Chemistry Buffer composition, chelators, reducing agents and competing proteins may influence GHK-Cu integrity
Sustainable therapies by engineered bacteria